ℹ️
🇬🇧
Search
Search for people relevant for "Cyfra 21-1"
Cyfra 21-1
Person
Class
Person
Publication
Programmes
RNDr. Pavlína Hašková Ph.D.
Academic staff at Faculty of Pharmacy in Hradec Králové
36 publications
Publications
publication
Examination of diverse iron-chelating agents for the protection of differentiated PC12 cells against oxidative injury induced by 6-hydroxydopamine and dopamine
2022 |
Faculty of Pharmacy in Hradec Králové
publication
Structure-Activity Relationships of Nitro-Substituted Aroylhydrazone Iron Chelators with Antioxidant and Antiproliferative Activities
2018 |
Faculty of Pharmacy in Hradec Králové
publication
Intravenous rutin in rat exacerbates isoprenaline-induced cardiotoxicity likely due to intracellular oxidative stress
2017 |
Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
publication
Design, Synthesis, and Biological Evaluation of Isothiosemicarbazones with Antimycobacterial Activity
2017 |
Faculty of Pharmacy in Hradec Králové
publication
Protective Effects of D-Penicillamine on Catecholamine-Induced Myocardial Injury
2016 |
Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové, First Faculty of Medicine
publication
Aroylhydrazone iron chelators: Tuning antioxidant and antiproliferative properties by hydrazide modifications
2016 |
Faculty of Pharmacy in Hradec Králové
publication
Characterization of cytoprotective and toxic properties of iron chelator SIH, prochelator BSIH and their degradation products
2016 |
Faculty of Pharmacy in Hradec Králové
publication
Cardioprotective effects of iron chelator HAPI and ROS-activated boronate prochelator BHAPI against catecholamine-induced oxidative cellular injury
2016 |
Faculty of Pharmacy in Hradec Králové
publication
Synthesis and analysis of novel analogues of dexrazoxane and its open-ring hydrolysis product for protection against anthracycline cardiotoxicity in vitro and in vivo
2015 |
Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
publication
In Vitro Characterization of the Pharmacological Properties of the Anti-Cancer Chelator, Bp4eT, and Its Phase I Metabolites
2015 |
Faculty of Pharmacy in Hradec Králové
Load more publications (26)
Loading network view...